• OneMedNet received a high six-figure add-on order under its multiyear agreement announced Sept. 30, 2026.
• The customer exercised an expansion option, increasing data volume by 150% to support its derivative dataset offering.
• The agreement retains potential recurring sublicensing revenue from future end-customer licenses of the partner-sold dataset.
• Source-data rights remain with OneMedNet; end customers cannot relicense or resell the underlying data.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onemednet Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611030840PRIMZONEFULLFEED9868987) on November 03, 2026, and is solely responsible for the information contained therein.